Australia #8118 (v.1)
Base data
- Notified in
-
G/MA/QR/N/AUS/5/Add.3 17/02/2022
- Version validity
-
08/01/2022 -
17/04/2022
Old version v.1
- Reporting member
- Australia
- In force from
- End date
- In force
- General description
-
Restriction on exports of COVID 19 rapid antigen test kits
- National legal basis
-
Biosecurity (Human Biosecurity Emergency) (Human Coronavirus with Pandemic Potential) (COVID-19 Rapid Antigen Tests) Determination 2022.
The Determination is made under subsection 477(1) of the Biosecurity Act 2015 (Cth). - Administrative mechanism
-
The Determination prohibits the exports of COVID-19 rapid antigen test kits unless an exception under section 9 of the Determination applies. Section 9 outlines exceptions for both non-commercial and commercial purposes.
This is a temporary measure to ensure that COVID-19 rapid antigen test kits are reasonably and appropriately available to individuals who require a test, as part of Australia’s public health response to controlling the spread of COVID-19. - Responsible entities
-
- HS version
-
HS 2017
- Referenced WTO document symbol
Meta data
- WTO justifications
-
XI:2(a) - (a) Export prohibitions or restrictions temporarily applied to prevent or relieve critical shortages of foodstuffs or other products essential to the exporting contracting party;
GATT 1994 (GATT 1947 provisions)
Reported as: GATT Art XI. 2(a) - Non-WTO commitments
-
- Affected partners
- Non-affected partners
Measures
- Reported restrictions
- CP-X
| Symbol |
|---|
|
CP-X
|
Tariff lines
|
3822
|
3822.19.09
|
COVID-19 rapid antigen test kit
|
|